UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
|
||
Washington, D.C. 20549
|
||
FORM 6-K
|
||
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934 |
||
For the month of April 2011
|
||
Commission File Number: 001-33340
|
||
TONGJITANG CHINESE MEDICINES COMPANY
|
||
(Translation of Registrant's name into English)
|
||
5th Floor, Block B
Nanshan Medical Device Park
1019 Nanhai Avenue, Shekou, Nanshan District
Shenzhen, 518067 Guangdong Province
People’s Republic of China
|
||
(Address of principal executive offices)
|
||
Indicate by check mark whether the registrant files or will file annual reports under the cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
|
||
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ___
|
||
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ___
|
||
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g-3-2(b) under the Securities Exchange Act of 1934. Yes o No x
|
||
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):
82-______________.
|
||
TONGJITANG CHINESE MEDICINES COMPANY | |||
|
By:
|
/s/ Justin Chen | |
Justin Chen
|
|||
Chief Operating Officer
|
|||
Exhibit
Number
|
Description
|
|
2.1
|
Agreement and Plan of Merger dated as of October 29, 2010, by and among Tongjitang Chinese Medicines Company, Fosun Industrial Co., Limited, Hanmax Investment Limited and Tonsun International Company Limited (incorporated by reference to Annex A to Exhibit 99.1 to the Transaction Statement on Schedule 13E-3 filed on February 23, 2011).
|
|
2.2
|
Amendment No. 1 to Agreement and Plan of Merger, dated as of February 21, 2011, by and among Tongjitang Chinese Medicines Company, Fosun Industrial Co., Limited, Hanmax Investment Limited and Tonsun International Company Limited, incorporated herein by reference to Annex A to the Proxy Statement (incorporated by reference to Annex A to Exhibit 99.1 to the Transaction Statement on Schedule 13E-3 filed on February 23, 2011).
|
|
99.1
|
Press release, dated April 15, 2011, entitled “Tongjitang Chinese Medicines Company Announces Closing of Merger and Intent to Delist from the NYSE.”
|